DekaBank Deutsche Girozentrale - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 113 filers reported holding MERSANA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$195,000
-28.8%
21,0000.0%0.00%0.0%
Q2 2021$274,000
-16.0%
21,0000.0%0.00%0.0%
Q1 2021$326,000
-42.6%
21,0000.0%0.00%
-50.0%
Q4 2020$568,000
+82.1%
21,000
+7.1%
0.00%0.0%
Q1 2018$312,000
-32.3%
19,600
-34.7%
0.00%
-50.0%
Q4 2017$461,0000.0%30,0000.0%0.00%0.0%
Q3 2017$461,000
-31.8%
30,000
-40.0%
0.00%
-20.0%
Q2 2017$676,00050,0000.01%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 818,033$14,144,00022.27%
ProQuest Associates IV LLC 955,709$16,524,00016.55%
NEA Management Company, LLC 8,144,267$140,814,0004.93%
Rock Springs Capital Management LP 1,330,000$22,996,0001.06%
Cormorant Asset Management, LP 295,549$5,110,0000.90%
ArrowMark Colorado Holdings LLC 477,711$8,260,0000.09%
Spark Investment Management LLC 18,688$323,0000.02%
WELLINGTON MANAGEMENT GROUP LLP 2,391,404$41,348,0000.01%
TUDOR INVESTMENT CORP ET AL 20,000$346,0000.01%
Laurion Capital Management LP 50,000$865,0000.00%
View complete list of MERSANA THERAPEUTICS INC shareholders